1998-1999 – The New York Presbyterian Hospital & Memorial Sloan Kettering Cancer Center (Cornell Residency Program) Internship in General Surgery
1999-2003 – The New York Presbyterian Hospital & Memorial Sloan Kettering Cancer Center (Cornell Residency Program) Residency in Neurosurgery
2003-2004 – The New York Presbyterian Hospital & Memorial Sloan Kettering Cancer Center (Cornell Residency Program) Chief Resident, Department of Neurological Surgery
2005-Σήμερα Νευροχειρουργός, Διαγνωστικό & Θεραπευτικό Κέντρο Αθηνών «Υγεία»
Sugiultzoglu MK, Zonenshayn M, Boland M, Bilsky M. J. Diagnosis and Management of vertebral osteomyelitis in patients of spinal metastases. Neurosurg. Spine. In progress
Sugiultzoglu MK, Souweidane, MM: Report of two cases of early management of craniocerebral injury with avoidance of post-traumatic leptomeningeal cyst formation. Pediatr. Neurosurg. 35:329-333, 2001
Rozniecki J, Letourneau R, Sugiultzoglu MK, Spanos CP, Gorbach J, and Theoharides TC. Differential release of Histamine-3 (H3) receptor active agents on brain but not peritoneal mast cell activation. J. Pharm. & Exper. Therap. 290(3): 1427-35, 1999
Manolides S, Sugiultzoglu MK, Schloss M: Ossifying fibroma of the skull base- a case report. Rivista Italiana di Otolaryngologia Autologia e Foniatria, Italy: 77-81, 1996
Rozniecky J, Sugiultzoglu MK, and Theoharides TC. Azatadine inhibits serotonin secretion from brain mast cells. Proc. 8th Intl. Congress on Immunology, Budapest: 159, 1992
Rozniecky J, Sugiultzoglu MK, and Theoharides TC: Histamine-3 (H3) receptor agonists inhibit brain mast cell and neuronal serotonin (5HT) secretion. FACEB J. 6:1559, 1992